You are here

avacopan

Flash FDA approval sends ChemoCentryx spiralling upwards

Pharmaforum

Sun, 10/10/21 - 09:48 pm

ANCA-positive vasculitis

Adcomm splits slightly in favor of FDA approving ChemoCentryx’s rare disease drug

Endpoints

Thu, 05/6/21 - 11:06 pm

advisory panels

ANCA-positive vasculitis

Chemocentryx takes a leap of faith with avacopan

EP Vantage

Thu, 10/29/20 - 12:13 pm

clinical trials

hidradenitis suppurativa

ChemoCentryx Drug Hits Co-Primary Endpoints in Phase III Vasculitis Trial

BioSpace

Tue, 11/26/19 - 11:37 pm

Vifor Fresenius Medical Care Renal Pharma

ANCA-positive vasculitis

clinical trials